BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 33108352)

  • 1. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
    Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity.
    Wang J; Farkas C; Benyoucef A; Carmichael C; Haigh K; Wong N; Huylebroeck D; Stemmler MP; Brabletz S; Brabletz T; Nefzger CM; Goossens S; Berx G; Polo JM; Haigh JJ
    PLoS Biol; 2021 Sep; 19(9):e3001394. PubMed ID: 34550965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.
    Stavropoulou V; Kaspar S; Brault L; Sanders MA; Juge S; Morettini S; Tzankov A; Iacovino M; Lau IJ; Milne TA; Royo H; Kyba M; Valk PJM; Peters AHFM; Schwaller J
    Cancer Cell; 2016 Jul; 30(1):43-58. PubMed ID: 27344946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia.
    Menendez-Gonzalez JB; Vukovic M; Abdelfattah A; Saleh L; Almotiri A; Thomas LA; Agirre-Lizaso A; Azevedo A; Menezes AC; Tornillo G; Edkins S; Kong K; Giles P; Anjos-Afonso F; Tonks A; Boyd AS; Kranc KR; Rodrigues NP
    Stem Cell Reports; 2019 Aug; 13(2):291-306. PubMed ID: 31378673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
    Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
    Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature.
    Corrigan DJ; Luchsinger LL; Justino de Almeida M; Williams LJ; Strikoudis A; Snoeck HW
    J Clin Invest; 2018 Aug; 128(8):3250-3264. PubMed ID: 29878897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.
    Park SM; Cho H; Thornton AM; Barlowe TS; Chou T; Chhangawala S; Fairchild L; Taggart J; Chow A; Schurer A; Gruet A; Witkin MD; Kim JH; Shevach EM; Krivtsov A; Armstrong SA; Leslie C; Kharas MG
    Cell Stem Cell; 2019 Jan; 24(1):153-165.e7. PubMed ID: 30472158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C.
    Zhu N; Chen M; Eng R; DeJong J; Sinha AU; Rahnamay NF; Koche R; Al-Shahrour F; Minehart JC; Chen CW; Deshpande AJ; Xu H; Chu SH; Ebert BL; Roeder RG; Armstrong SA
    J Clin Invest; 2016 Mar; 126(3):997-1011. PubMed ID: 26878175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential niche and Wnt requirements during acute myeloid leukemia progression.
    Lane SW; Wang YJ; Lo Celso C; Ragu C; Bullinger L; Sykes SM; Ferraro F; Shterental S; Lin CP; Gilliland DG; Scadden DT; Armstrong SA; Williams DA
    Blood; 2011 Sep; 118(10):2849-56. PubMed ID: 21765021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway.
    Zhao C; Du F; Zhao Y; Wang S; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):384. PubMed ID: 31842997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.
    Wang Y; Krivtsov AV; Sinha AU; North TE; Goessling W; Feng Z; Zon LI; Armstrong SA
    Science; 2010 Mar; 327(5973):1650-3. PubMed ID: 20339075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
    Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
    J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.
    Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH
    J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional memory of cells of origin overrides β-catenin requirement of MLL cancer stem cells.
    Siriboonpiputtana T; Zeisig BB; Zarowiecki M; Fung TK; Mallardo M; Tsai CT; Lau PNI; Hoang QC; Veiga P; Barnes J; Lynn C; Wilson A; Lenhard B; So CWE
    EMBO J; 2017 Nov; 36(21):3139-3155. PubMed ID: 28978671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.
    Zhu XN; Wei YS; Yang Q; Liu HR; Zhi Z; Zhu D; Xia L; Hong DL; Yu Y; Chen GQ
    J Hematol Oncol; 2023 Feb; 16(1):9. PubMed ID: 36774506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
    Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
    Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenance.
    Vukovic M; Guitart AV; Sepulveda C; Villacreces A; O'Duibhir E; Panagopoulou TI; Ivens A; Menendez-Gonzalez J; Iglesias JM; Allen L; Glykofrydis F; Subramani C; Armesilla-Diaz A; Post AE; Schaak K; Gezer D; So CW; Holyoake TL; Wood A; O'Carroll D; Ratcliffe PJ; Kranc KR
    J Exp Med; 2015 Dec; 212(13):2223-34. PubMed ID: 26642852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.